Carlos Luis Lopez
CIK 2042509 · SVP, General Counsel · last filed 2026-07-08
Carlos Luis Lopez is a SVP, General Counsel who has filed 4 SEC Form 4 insider transactions across 2 companies since 2025. The most recent filing shows the insider was granted $6.3K of NAGE on Jul 8, 2026. Across all open-market trades the lifetime net is +$2.1K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $14.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$14.1K
2
4
$2.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NAGE | SVP, General Counsel | 4,565 | $3.08 | $14.1K | $0 | 2 | 2026-07-08 |
| Niagen Bioscience, Inc. (CDXC) Delisted | SVP, General Counsel | 2,251 | $7.87 | $17.7K | $2.1K | 2 | 2025-03-10 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-08 | NAGE | Grant (A) | +2,314 | $6.3K | EDGAR |
| 2026-02-24 | NAGE | Grant (A) | — | $0 | EDGAR |
| 2025-03-10 | Niagen Bioscience, Inc. (CDXC) Delisted | Buy (P) | +273 | $2.1K | EDGAR |
| 2025-02-14 | Niagen Bioscience, Inc. (CDXC) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.